AI-based screening for pediatric DRD is more cost-effective and increases screening rates compared to traditional ECP methods ...

NICE, in collaboration with other international health technology assessment agencies, has published a new report which ...

A study from Spain found a subcutaneous tocilizumab biosimilar to be cost-effective when treating patients with rheumatoid ...

Cost-effectiveness and optimal stopping ages for colorectal cancer screening after age 75 years appear to be associated with ...

For overweight or obese individuals without diabetes, but with pre-existing cardiovascular disease, semaglutide (Ozempic, Wegovy) is not cost-effective at current pricing, new research shows. However, ...

The cost-effectiveness analysis was conducted ... budgets in the U.S. to prevent CVD and improve population health. “This specific analysis was motivated by results from the SCCS.

For overweight or obese individuals without diabetes, but with pre-existing cardiovascular disease, semaglutide (Ozempic, Wegovy) is not cost-effective at current pricing, new research shows.

Antibiotic overuse is a key driver in the rise of antimicrobial resistance (AMR), a major global health crisis. Researchers have provided compelling evidence that short-course antibiotic treatments ...

The anti-obesity drug Zepbound made by Eli Lilly & Co. could be one of the biggest cost drivers for ... [+] health insurers, employers and government health programs who cover it in 2025.

Scientists discover amazing new way to predict stroke risk through simple eye scans. Learn how 29 unique retinal markers ...

By embedding analytics into their benefits strategy, organizations can move beyond reactive cost management to proactive plan ...